Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study.

Lundin, Evelyn S

Single-dose tranexamic acid in advanced ovarian cancer surgery reduces blood loss and transfusions: double-blind placebo-controlled randomized multicenter study. [electronic resource] - Acta obstetricia et gynecologica Scandinavica Apr 2014 - 335-44 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1600-0412

10.1111/aogs.12333 doi


Adult
Aged
Aged, 80 and over
Antifibrinolytic Agents--administration & dosage
Blood Loss, Surgical--prevention & control
Double-Blind Method
Drug Administration Schedule
Erythrocyte Transfusion--statistics & numerical data
Female
Gynecologic Surgical Procedures--adverse effects
Hemoglobins--metabolism
Humans
Injections, Intravenous
Middle Aged
Neoplasm Staging
Odds Ratio
Operative Time
Ovarian Neoplasms--blood
Ovariectomy--adverse effects
Preoperative Care--methods
Primary Prevention--methods
Sweden--epidemiology
Tranexamic Acid--administration & dosage
Treatment Outcome